Ocular Therapeutix Inc (OCUL)
6.41
-0.59
(-8.43%)
USD |
NASDAQ |
Apr 04, 14:57
Ocular Therapeutix Profit Margin (Quarterly): -283.3% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | -357.3% |
| TG Therapeutics Inc | 21.57% |
| ADMA Biologics Inc | 95.19% |
| Cara Therapeutics Inc | -527.8% |
| Ocugen Inc | -1.82K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -62.66% |
| Return on Assets | -42.88% |
| Return on Invested Capital | -51.22% |
| Gross Profit Margin (Quarterly) | 92.80% |
| Operating Margin (Quarterly) | -296.1% |
| Return on Net Operating Assets | -399.6% |